152 related articles for article (PubMed ID: 17342498)
1. Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid.
Oderda G; Asche C; Jones KP; Merrill RM; Spalding J
Arch Gynecol Obstet; 2007 Sep; 276(3):211-8. PubMed ID: 17342498
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
Volkers NA; Hehenkamp WJ; Smit P; Ankum WM; Reekers JA; Birnie E
J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
[TBL] [Abstract][Full Text] [Related]
3. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
Goldberg J; Bussard A; McNeil J; Diamond J
Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
[TBL] [Abstract][Full Text] [Related]
4. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
Dembek CJ; Pelletier EM; Isaacson KB; Spies JB
J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
[TBL] [Abstract][Full Text] [Related]
5. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
Becker ER
J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids.
Beinfeld MT; Bosch JL; Isaacson KB; Gazelle GS
Radiology; 2004 Jan; 230(1):207-13. PubMed ID: 14695395
[TBL] [Abstract][Full Text] [Related]
7. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
You JH; Sahota DS; Yuen PM
Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
[TBL] [Abstract][Full Text] [Related]
8. The economic impact of uterine fibroids in the United States: a summary of published estimates.
Mauskopf J; Flynn M; Thieda P; Spalding J; Duchane J
J Womens Health (Larchmt); 2005 Oct; 14(8):692-703. PubMed ID: 16232101
[TBL] [Abstract][Full Text] [Related]
9. Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids.
Harrington A; Bonine NG; Banks E; Shih V; Stafkey-Mailey D; Fuldeore RM; Yue B; Ye JM; Ta JT; Gillard P
J Manag Care Spec Pharm; 2020 Jan; 26(1-a Suppl):S2-S10. PubMed ID: 31958025
[TBL] [Abstract][Full Text] [Related]
10. Hospitalization costs associated with leiomyoma.
Zhao SZ; Wong JM; Arguelles LM
Clin Ther; 1999 Mar; 21(3):563-75. PubMed ID: 10321423
[TBL] [Abstract][Full Text] [Related]
11. Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study.
Wu O; Briggs A; Dutton S; Hirst A; Maresh M; Nicholson A; McPherson K
BJOG; 2007 Nov; 114(11):1352-62. PubMed ID: 17949377
[TBL] [Abstract][Full Text] [Related]
12. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
Coyne KS; Margolis MK; Murphy J; Spies J
Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
[TBL] [Abstract][Full Text] [Related]
13. Contemporary treatment utilization among women diagnosed with symptomatic uterine fibroids in the United States.
Bonine NG; Banks E; Harrington A; Vlahiotis A; Moore-Schiltz L; Gillard P
BMC Womens Health; 2020 Aug; 20(1):174. PubMed ID: 32791970
[TBL] [Abstract][Full Text] [Related]
14. Health care resource use for uterine fibroid tumors in the United States.
Flynn M; Jamison M; Datta S; Myers E
Am J Obstet Gynecol; 2006 Oct; 195(4):955-64. PubMed ID: 16723104
[TBL] [Abstract][Full Text] [Related]
15. What are the total costs of surgical treatment for uterine fibroids?
Carls GS; Lee DW; Ozminkowski RJ; Wang S; Gibson TB; Stewart E
J Womens Health (Larchmt); 2008 Sep; 17(7):1119-32. PubMed ID: 18687032
[TBL] [Abstract][Full Text] [Related]
16. Medical and socioeconomic impact of uterine fibroids.
Greenberg MD; Kazamel TI
Obstet Gynecol Clin North Am; 1995 Dec; 22(4):625-36. PubMed ID: 8786874
[No Abstract] [Full Text] [Related]
17. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy.
Istre O
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):735-47. PubMed ID: 18328788
[TBL] [Abstract][Full Text] [Related]
18. Annual costs associated with diagnosis of uterine leiomyomata.
Hartmann KE; Birnbaum H; Ben-Hamadi R; Wu EQ; Farrell MH; Spalding J; Stang P
Obstet Gynecol; 2006 Oct; 108(4):930-7. PubMed ID: 17012456
[TBL] [Abstract][Full Text] [Related]
19. Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma.
Jacobson GF; Shaber RE; Armstrong MA; Hung YY
Am J Obstet Gynecol; 2007 Jun; 196(6):601.e1-5; discussion 601.e5-6. PubMed ID: 17547914
[TBL] [Abstract][Full Text] [Related]
20. Contemporary management of uterine fibroids: focus on emerging medical treatments.
Singh SS; Belland L
Curr Med Res Opin; 2015 Jan; 31(1):1-12. PubMed ID: 25365466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
